Cornerstone Advisors (Washington)’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-192
Closed -$15K 966
2016
Q4
$15K Buy
192
+40
+26% +$3.17K 0.01% 550
2016
Q3
$12K Hold
152
0.01% 576
2016
Q2
$12K Buy
152
+58
+62% +$4.14K 0.01% 393
2016
Q1
$5K Buy
94
+47
+100% +$2.56K 0.01% 579
2015
Q4
$3K Sell
47
-294
-86% -$18.5K ﹤0.01% 686
2015
Q3
$22K Buy
341
+23
+7% +$1.64K 0.02% 303
2015
Q2
$23K Hold
318
0.02% 240
2015
Q1
$21K Buy
318
+272
+591% +$18.1K 0.02% 276
2014
Q4
$3K Buy
46
+22
+92% +$1.42K ﹤0.01% 527
2014
Q3
$1K Sell
24
-10
-29% -$653 ﹤0.01% 588
2014
Q2
$2K Hold
34
﹤0.01% 522
2014
Q1
$2K Buy
34
+12
+55% +$781 ﹤0.01% 427
2013
Q4
$1K Hold
22
﹤0.01% 356
2013
Q3
$1K Hold
22
﹤0.01% 333
2013
Q2
$1K Buy
+22
New +$953 ﹤0.01% 286

Other funds holding STJ

Cornerstone Advisors (Washington)'s STJ Position: Q1 2017 in Review

Cornerstone Advisors (Washington) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 192 shares — an estimated $15K sold.

Cornerstone Advisors (Washington) first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $23K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Cornerstone Advisors (Washington) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 192 St Jude Medical shares in Q1 2017, an estimated $15K.
  • Cornerstone Advisors (Washington) first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Cornerstone Advisors (Washington)'s St Jude Medical position peaked at $23K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q1 2017, filed 27 Apr 2017.